Study Assessing Hybrid SPECT-CT With Labeled Leukocytes for Diagnosis of Vascular Prosthesis Infections — LEUCOPRO  

Vascular Prosthesis Infection Clinical Trial

Official title: Tomoscintigraphie Hybride Aux Leucocytes Marqués Dans le Diagnostic Des Infections de Prothèses Vasculaires.

Status Recruiting

Clinical Trial Summary

Vascular Prothesis Infection is a rare but an extremely serious complication. Diagnosis is often difficult (germs are found only in 50% of cases). Conventional imagery is often non-specific and difficult to interpret especially in early postoperative phase. Leukocytes isolated from the patient's blood are labeled with a radiopharmaceutical technetium 99mTc-HMPAO.

The aim of this study is to assess the overall diagnostic performance of scintigraphy (hybrid SPEC-CT) with labeled leucocytes in diagnosis of subdiaphragmatic vascular prothesis infection.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Vascular Prosthesis Infection

• NCT number: NCT02538133
• Study type: Interventional
• Source: University Hospital, Angers
• Contact: HERVE RAKOTONIRINA, Dr
• Phone: +33(0)241353412
• Email: HeRakotonirina@chu-angers.fr
• Status: Recruiting
• Phase: Phase 3
• Start date: September 2015
• Completion date: January 2020